Abstract Clinical trials are considered the gold standard of evidence about the efficacy of cancer prevention, early detection, and treatment interventions. A paucity of data exists on determinants of clinical trial participation in the growing US Latino population despite poor cancer outcomes in this group. This study seeks to describe correlates of awareness of and willingness to participate in clinical trials among largely Central, North, and South American Latinos using safety-net clinics. Between June 2007 and November 2008, we conducted an interviewer-administered, Spanish-language cross-sectional survey (n = 944). Logistic regression was used to assess effects of health information sources and psychosocial variables on awareness of and intention to participate in clinical trials. Analyses were completed in spring 2010. While only 48% knew what a clinical trial was, when explained, 65% indicated a willingness to participate. Providers were the most common source of health information. Use of Internet for health information, trust in health information, and higher education each independently increased the odds of clinical trial awareness, but obtaining information from providers did not. Contacting the Cancer Information Service and psychosocial factors were each independently associated with intent to join a clinical trial, while demographic factors were not. Information channels such as the Internet may be effective in conveying clinical trial information to Latinos. Providers being cited as the most common source of health information but not being associated with knowledge about or intent to participate in trials suggests a missed opportunity for communication to this population.
Introduction
Clinical trials are considered the gold standard of evidence about the efficacy of cancer prevention, early detection, and treatment interventions. Broad population representation in clinical trials is important to ensure that results translate into population effectiveness. However, only 3% of adult cancer patients in the United States (US) participate in clinical trials [1] , and enrollment is even lower for minorities [2, 3] . This is particularly true for Latinos, the fastest growing and largest minority group in the US. Latinos currently comprise 15.4% of the population and are projected to represent 25% of the US population by 2050 [4, 5] . Cancer is the second leading cause of death in Latinos, and this group has disproportionately high mortality rates [6] but comprises only 2-3% of enrollees in cancer clinical trials [1, 5] .
In non-Latinos, higher levels of education, awareness of clinical trials, physician referrals, and positive beliefs about the balance of benefits and risks of research are associated with trial participation [7] . However, less is known about clinical trial participation in Latinos [8] . Limited Latino patient-provider communication, difficulties in accessing health care, and lack of awareness may be related to lower trial enrollment [9, 10] . Interestingly, when aware of or offered participation in clinical trials, Latinos enroll at the same rates as non-Latino Whites [8, 9, 11] . Mainly, this nascent body of literature on Latino clinical trial participation has focused on those of Mexican ancestry.
Researchers present data from a cross-sectional survey of largely immigrant Central, North, and South American Latinos using safety-net clinics to assess information channels for and correlates of clinical trial awareness. They hypothesized that (1) greater Spanish-language media use and Internet use would each be independently associated with clinical trial awareness; and (2) psychosocial factors such as higher perceived risk of or worry about cancer, greater self-efficacy in information gathering, and trust in medical information would also be independently associated with clinical trial awareness and willingness to participate after considering covariates. These data seek to inform future interventions, increase broader enrollment of Latinos in future cancer clinical trials, and ultimately contribute to reducing cancer disparities in this vulnerable population.
Materials and Methods
This study evaluates the information needs, informationseeking styles, and cancer knowledge of Latinos in the DC metropolitan area. This research was conducted as part of the National Cancer Institute-funded Latin American Cancer Research Coalition (LACRC). All study procedures were approved by the participating Institutional Review Boards.
Setting
This study was conducted in nine safety-net LACRC partner community clinics. The clinics provide services primarily to Latinos on a slide-scale fee; several are federally funded community health centers. A total of 1,482 surveys were completed. Researchers excluded those with unknown region of birth (n = 86) or the small number born outside of Central, North, and South America (n = 1 from Congo, 1 from Spain, and 43 from the Caribbean), leaving 1,351 available for analysis. Of the analytic sample, 96% (n = 1,297) were recruited from clinics and 4% (n = 54) from health fairs.
Data Collection
Researchers developed a structured interview instrument using existing validated Spanish-language instruments, including items that had been successfully administered in the Spanish-language version of the Health Information National Trends (HINTS) survey [12] . Data were collected between June 2007 and November 2008. Trained bicultural and bilingual cancer control coordinators conducted the face-to-face interviews in a private space; interviews lasted about 30 min and were conducted in the participant's language choice (99% in Spanish).
Measures

Primary Outcomes
The two outcome variables for the analyses were clinical trial awareness and intention to participate in a clinical trial. Awareness of trials was assessed by a multiple-choice question: ''Please tell me which one of the five definitions you think describes a clinical trial?'' Response options were a project in a clinic; a test in an MD's office; a research project in which some patients are selected to try new treatment medications while others receive different medications or none at all; a group of medical students; or unsure. Intention to participate in a trial was assessed after explanation of a clinical trial using responses to the item: ''In the future, if you developed a health problem like cancer, would you consider joining a clinical trial that was testing a new cancer treatment that could help you?'' Response options were I would not participate; I might participate; I probably would participate; I definitely would participate; or not sure/haven't thought about it. Since these items were added while the survey was in the field, data for these outcomes were unavailable from the first one-third of surveys. As such, 407 (30%) individuals were excluded from the sample of 1,351 respondents, leaving a final analytic sample of 944 men and women.
Independent Variables
Information-Seeking Behavior
To assess information-seeking behavior, participants were asked how often (not at all, very little, somewhat, quite a bit, always) they sought health information from the following sources: newspapers, magazines, radio, television, the Internet, health professionals (such as doctors and nurses, health educators/navigators, community leaders/ priests, health fairs, and ''Charlas de Salud''). Participants were also asked how much they trusted the information they received from each of these sources.
Personal Cancer Risk
Researchers measured perceptions of personal cancer risk by asking participants, ''In your opinion, how likely is it that you will develop cancer?'' with possible responses ranging from not at all likely to definitely on a 5-point scale.
Cancer Worry
Researchers measured worry by asking participants, ''In the past month, how often have you worried about your own chances of getting cancer?'' with possible responses ranging from not at all or rarely to a lot on a 4-point scale.
Information Self-Efficacy
An eight-question scale, modified from the Seeking and Understanding Medical Information Subscale from the Cancer Behavior Inventory, was used to measure selfefficacy. Participants were asked to choose a number between 1 and 9, where 1 represented not at all confident and 9 represented totally confident in response to phrases such as ''How confident are you that you can ask nurses questions about cancer?'' Responses were summed and averaged to create a composite score; individuals were only given a score if they answered all eight items.
Control Variables
Demographic Variables
Standard demographic information was obtained from participants, including age, gender, marital status, country of origin, highest grade completed, and number of years in the US. Finally, researchers measured language acculturation using the four-item scale developed by Marin et al. [13] .
Data Analysis
Researchers evaluated the associations between each outcome and study variables using t tests and v 2 tests. For each outcome, the adjusted odds ratios (OR) and 95% confidence intervals (CI) were estimated using multivariable logistic regression. Variable selection for the final multivariable model was based on the significance (at 0.05 level) of univariable associations for that outcome; variables that were not significant at the 0.05 level were removed from the final model. Certain factors such as age and acculturation were retained in the final models, even if not statistically significant, to enhance face validity. Model fit was assessed using Hosmer-Lemeshow Goodness of Fit test. Analyses were conducted using SAS 9.2 (SAS Institute, Inc., Cary, NC) and were completed spring 2010.
Results
More than half of the respondents in this safety-net clinic population were from Central America (65%), and the majority had 12 or fewer years of education (75%). Acculturation levels were also low (mean 1.5 score; SD = 0.7 on a 1-5 scale, with 1 indicating the lowest acculturation; Table 1 ). The primary source of health information reported was health care providers (66%) followed by the media (27%). Use of the National Cancer Institute Spanish Cancer Information Service (CIS) for cancer information was very low. Slightly less than half of the respondents had access to the Internet (41%); among those with access, 78% used it to seek health information and 54% reported use for cancer information. Most Internet sites used for health information were Spanish-language pages (not shown).
Predictors of Clinical Trial Knowledge
Only one-half of respondents could correctly identify what a clinical trial was. Despite the high use of providers for information, in invariable analyses, this health information channel was not associated with correct knowledge of a clinical trial. However, respondents who used the Internet for health information had greater knowledge than respondents who did not have Internet access (P \ 0.001; Table 1 ). Socio-demographic factors were also associated with higher levels of correct knowledge about RCTs. These factors remained significant after considering the other covariates (Table 2) . For instance, after controlling for other characteristics, respondents who used the Internet to Psychosocial factors were also independent correlates of knowledge, with those reporting greater trust in health information from health sources having higher odds of correct knowledge about clinical trials (OR = 1.33, 95% CI 1.12-1.58, P = 0.001) than those with less trust.
Predictors of Intention to Join a Clinical Trial
Univariable results indicate that psychosocial factors including trust in health information, greater worry about cancer, and higher information self-efficacy were associated with intent to enroll in a clinical trial, while demographic factors were not (Table 1) . Despite low use, those who used CIS as an information source reported greater intention to join a trial than those who did not use CIS (83% vs. 64%, P = 0.01). Those who could correctly identify the definition of a clinical trial stated that they would enroll in a trial more often than those who did not know what a trial was (71% vs. 60%, P = 0.001). All of these relationships remained significant in multivariable analyses (Table 3 ). For instance, those who called CIS reported odds of intent to join a clinical trial that were 2.49 (95% CI 1.01-6.14, P = 0.05) times higher than respondents who had not called CIS.
Discussion
This is one of the first studies to describe the knowledge of and intention to participate in cancer clinical trials among low acculturated, immigrant Latinos in safety-net clinics. While only one-half of this vulnerable population knew what a clinical trial was, when explained, 65% indicated a P values were computed using v 2 tests for categorical characteristics and t-tests for continuous characteristics SD standard deviation, CIS cancer information service Self-efficacy ranges from 1 to 9 with higher scores reflecting higher self-efficacy Acculturation ranges from 1 to 5 with higher scores reflecting higher acculturation Trust in health information ranges from 1 to 5 with higher scores reflecting higher trust J Community Health (2012) 37:335-343 339 willingness to participate. Information channels, including the Internet and Spanish-language telephone call centers, appear to be effective in conveying clinical trial information. While providers were cited as a common source of health information, obtaining information from providers was not associated with clinical trial knowledge or intent to participate. Psychosocial but not demographic factors were related to intent to join a cancer clinical trial. The rate of interest in clinical trials observed in this Latino sample (65%) is fairly similar to Wendler et al.'s [14] sample, comprised of largely African-Americans and Latinos from the US, where 56% of Latinos were willing to participate in clinical trials when offered accurate information. Research provides further evidence that when asked to participate in clinical trials, minorities, including Latinos, are willing to do so and enroll at the same rates as non-Hispanic Whites [15] . Additional factors such as whether participants are informed of research opportunities, medical eligibility, and personal circumstances (i.e., child care demands, job flexibility, and geographic proximity to research sites) are important to clinical trial awareness and participation [9, 16] . This study's population had a higher-than-expected rate of Internet use, and 78% of those with access reported using the Internet for cancer information. Nationally, the Pew Hispanic Center Internet Project reports that 56% of Latinos use the Internet [17] . In this sample, those using the Internet for health information were more likely to know about clinical trials, and that knowledge was in turn associated with intent to participate. The Internet has been used to assist in health care decision making [18] . Despite Latino's slightly lower use than other ethnic groups [17, 19] , Spanish-language Internet sites have the potential to reach a large number of Latinos about cancer clinical trials.
Use of a national information channel such as CIS was very low (4%) in this Latino population, considering services are available in Spanish. In other populations, CIS has been a valuable source for clinical trial and cancer information [20, 21] . In this population, researchers would expect a similar result with use of the CIS Spanish call center being associated with intention to participate in clinical trials. Given the cross-sectional nature of this study, researchers cannot determine if information imparted by CIS resulted in interest in clinical trials, or if those who were motivated to join trials were also more likely to call CIS for other cancer information. Even under the latter scenario, it appears that CIS provided sufficient information to reinforce the value of research and importance of joining clinical trials.
Physicians are also a critical source of health information and strong motivators of general cancer-related behaviors in Latino and other ethnic minority populations [22] [23] [24] [25] [26] [27] . In this study, providers were cited as the primary source of health information, yet surprisingly this information source was not associated with clinical trial knowledge or intent to participate. This apparent paradox may have several explanations. Many of the safety-net clinics participating in this study rely on volunteer providers. It is possible that these volunteers are too busy to provide cancer health education, since the volume of patients requesting care exceeds capacity in these clinics.
Another explanation is that trials are not easily available or offered via safety-net clinics. In addition, given the pressing acute health care needs of safety-net clinic populations, discussion of clinical trials may not be especially salient. Since Latino providers are considered respected leaders in the Latino community [28, 29] and were considered a trusted source of health information in this study, there may be a missed opportunity for providers to convey education about clinical trials. Thus, further research is needed to better understand patient-provider communication about clinical trials, particularly with Latinos.
The study findings suggest that when Latinos know about RCTs, they are willing to participate. Similar findings of Umatyan et al. [11] give credence to the importance of clinical trial awareness. The null results for associations between demographic factors and intent to participate in trials may further indicate that information campaigns may not have to be tailored to these characteristics. However, it is possible that researchers obtained null results because their population was fairly demographically homogenous; these competing hypotheses will be important to test in future research with more heterogeneous Latino subgroups from broader settings.
These findings suggest, however, that psychosocial factors have the potential to be leveraged for intervention use to increase clinical trial participation. For instance, those with high trust in health information had higher odds of knowing about and being willing to participate in clinical trials. The fact that this population was receiving care in safety-net Latino-focused clinics with bilingual staff may have increased their trust of health information [22, 25] . If this is confirmed in future research, messages about trials could be linked to trust information sources like clinics and/or include content that enhances their credibility in the Latino population [30] . Additionally, since prior research has shown that increased self-efficacy plays a role in a variety of health behaviors [26, 27, 29] , enhancing self-efficacy in obtaining trial information could be used to increase interest in trial participation. The result that Latinos with higher perceived cancer risk were more interested in trial participation is consistent with research in other populations that has shown that risk perceptions are linked to cancer-related health behaviors [31, 32] . Since Latinos (and other groups) generally overestimate their cancer risk [33] , it will be important to determine the utility of using risk education to increase interest in clinical trials.
Study limitations should be considered, including crosssectional and quota design, external generalizability, and measurement issues. Due to the cross-sectional nature of this study, researchers cannot make any inferences regarding causality. Prospective studies will be important to determine directionality of the results observed. Researchers employed a quota sampling scheme to estimate age-and gender-specific health behaviors, so they cannot calculate true clinic-wide prevalence rates regarding attitudes toward clinical trials. Their sample was a fairly homogenous immigrant, monolingual Latino group, mostly from Central, North, and South America, who relied on safety-net clinics for their care and may not be representative of other North, Central, and South American groups or other Latino populations. However, uninsured groups relying on safety-net care have been noted to present at late stages of cancer, have difficulty accessing timely and quality treatment, and be under-represented in clinical trials (that often require health insurance to cover the costs of trial-induced monitoring tests) [34] [35] [36] . Information about this study's population potentially can be used to increase access to prevention, early detection, and treatment clinical trials, and ultimately improve outcomes for vulnerable subgroups. Researchers used perceived risk measures and did not have data on actual cancer risk; it will be interesting to assess how actual risk affects trial enrollment in future research. The researchers' measure of knowledge was based on only one question, but this question has been shown to relate to willingness to participate in trials in an earlier study in this same setting [33] . Finally, researchers do not know how intention to participate in a trial relates to actual behavior, since there were no trials available to offer this population at the time of the study.
This study addresses an important knowledge gap about clinical trial information needs and intentions in the growing Latino population. As cancer is the second leading cause of death in this group, it is important that Latinos be represented in clinical trials to ensure generalizability of results and equitably benefit from advances in cancer scientific knowledge and discovery.
